James R. Meyer's most recent trade in Sangamo Therapeutics Inc was a trade of 50,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 12, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Sangamo Therapeutics Inc | James R. Meyers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2025 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Sangamo Therapeutics Inc | James R. Meyers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2025 | 25,000 | 99,600 (0%) | 0% | 0 | Common Stock | |
| CytomX Therapeutics Inc | James R. Meyers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2025 | 38,000 | 38,000 | - | - | Stock Option (Right to Buy) | |
| FreightCar America Inc | James R. Meyer | Director | Grant, award, or other acquisition of securities at price $ 7.17 per share. | 14 May 2025 | 10,460 | 27,787 (0%) | 0% | 7.2 | 74,998 | Common Stock |
| FreightCar America Inc | James R. Meyer | Director | Purchase of securities on an exchange or from another person at price $ 10.74 per share. | 14 Nov 2024 | 23,400 | 838,278 (6%) | 0% | 10.7 | 251,316 | Common Stock |
| Sangamo Therapeutics Inc | James R. Meyers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Sangamo Therapeutics Inc | James R. Meyers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 25,000 | 74,600 (0%) | 0% | 0 | Common Stock | |
| Arbutus Biopharma Corp | James R. Meyers | Director | 23 May 2024 | 67,000 | 67,000 | - | - | Stock Option (Right to Buy) | ||
| CytomX Therapeutics Inc | James R. Meyers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2024 | 38,000 | 38,000 | - | - | Stock Option (Right to Buy) | |
| FreightCar America Inc | James R. Meyer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 May 2024 | 20,408 | 814,878 (6%) | 0% | 0 | Common Stock | |
| FreightCar America Inc | James Meyer R. | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2024 | 241,500 | 241,500 | - | - | Employee Stock Option | |
| FreightCar America Inc | James R. Meyer | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2024 | 171,704 | 794,470 (5%) | 1% | 0 | Common Stock | |
| CytomX Therapeutics Inc | James R. Meyers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Sangamo Therapeutics Inc | James R. Meyers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 27,750 | 27,750 | - | - | Stock Option (Right to Buy) | |
| Sangamo Therapeutics Inc | James R. Meyers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 13,900 | 49,600 (0%) | 0% | 0 | Common Stock | |
| Arbutus Biopharma Corp | James R. Meyers | Director | 24 May 2023 | 55,000 | 55,000 | - | - | Stock Option (Right to Buy) | ||
| FreightCar America Inc | James R. Meyer | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 2.78 per share. | 12 May 2023 | 15,251 | 622,766 (4%) | 0% | 2.8 | 42,398 | Common Stock |
| FreightCar America Inc | James R. Meyer | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 2.95 per share. | 12 May 2023 | 12,427 | 17,327 (0%) | 0% | 3.0 | 36,660 | Common Stock |
| FreightCar America Inc | James R. Meyer | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 2.85 per share. | 12 May 2023 | 4,900 | 4,900 (0%) | 0% | 2.9 | 13,965 | Common Stock |
| FreightCar America Inc | James R. Meyer | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jan 2023 | 42,815 | 0 | - | - | Employee Restricted Stock Unit | |
| FreightCar America Inc | James R. Meyer | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Jan 2023 | 42,815 | 607,515 (4%) | 0% | - | Common Stock | |
| FreightCar America Inc | James R. Meyer | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 188,585 | 188,585 | - | - | Employee Stock Option | |
| FreightCar America Inc | James R. Meyer | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2023 | 131,599 | 564,700 (4%) | 0% | 0 | Common Stock | |
| CytomX Therapeutics Inc | James R. Meyers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Arbutus Biopharma Corp | James R. Meyers | Director | 25 May 2022 | 41,000 | 41,000 | - | - | Stock Option (Right to Buy) | ||
| FreightCar America Inc | James R. Meyer | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 3.64 per share. | 11 May 2022 | 25,000 | 433,101 (3%) | 0% | 3.6 | 91,000 | Common Stock |
| Sangamo Therapeutics Inc | James R. Meyers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2022 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Sangamo Therapeutics Inc | James R. Meyers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2022 | 12,500 | 35,700 (0%) | 0% | 0 | Common Stock | |
| FreightCar America Inc | James R. Meyer | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2022 | 161,402 | 161,402 | - | - | Employee Stock Option | |
| FreightCar America Inc | James R. Meyer | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2022 | 110,929 | 408,101 (3%) | 0% | 0 | Common Stock | |
| CytomX Therapeutics Inc | James R. Meyers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2021 | 20,000 | 20,000 | - | - | Stock Option (Right to Buy) | |
| Arbutus Biopharma Corp | James R. Meyers | Director | 03 Jun 2021 | 22,000 | 22,000 | - | - | Stock Options | ||
| Sangamo Therapeutics Inc | James R. Meyers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2021 | 16,400 | 16,400 | - | - | Stock Option (Right to Buy) | |
| Sangamo Therapeutics Inc | James R. Meyers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2021 | 8,200 | 23,200 (0%) | 0% | 0 | Common Stock | |
| FreightCar America Inc | James R. Meyer | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2021 | 113,276 | 113,276 | - | - | Employee Stock Option | |
| FreightCar America Inc | James R. Meyer | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2021 | 65,617 | 297,172 (2%) | 0% | 0 | Common Stock | |
| FreightCar America Inc | James R. Meyer | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2021 | 750,000 | 750,000 | - | - | Employee Stock Option | |
| FreightCar America Inc | James R. Meyer | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 2.61 per share. | 30 Nov 2020 | 17,500 | 231,555 (1%) | 0% | 2.6 | 45,603 | Common Stock |
| FreightCar America Inc | James R. Meyer | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 1.98 per share. | 25 Nov 2020 | 22,500 | 209,055 (1%) | 0% | 2.0 | 44,507 | Common Stock |
| FreightCar America Inc | James R. Meyer | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 2.81 per share. | 25 Nov 2020 | 5,000 | 214,055 (1%) | 0% | 2.8 | 14,060 | Common Stock |